Image
02.06.2023
Life-changing ‘bionic pancreas’ for type 1 diabetes available in t...
A ‘bionic pancreas’ that combines an insulin pump and automated dosing software has been approved by the ...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more